Jeremy Kasdin
Paul Romness, CEO of OS Therapies, provides a post-listing update on the company’s progress, achievements, and future plans. Romness discusses the milestones OS Therapies has reached since going public and how the company is creating innovation and hope within cancer treatment.
What’s next for OS Therapies? CEO Paul Romness gives a post-listing update
Host
